FDA Clears Cerebrotech Neurological Spectroscopy Device

The FDA cleared Cerebrotech Medical Systems’ Cerebrotech Visor, a bioimpedance spectroscopy device designed to aid clinicians in assessing cerebral fluid volumes.

The clearance includes a broad indication for use in assessing fluid volume differences between the cerebral hemispheres in patients undergoing neurologic assessment.

The device features the company’s proprietary machine learning technology for optimizing algorithms.